Melola Discovery

← Melola Discovery

Akses terbuka Jurnal SINTA 1

Survival analysis of diabetes mellitus and cardiovascular patients with COVID-19: a secondary data analysis

Public Health of Indonesia · Vol. 10 No. 2 (2024) · hlm. 143–156

DOI
10.36685/phi.v10i2.788
ISSN
2477-1570, 2528-1542
Terbit
2024-06-25
Penerbit
YCAB Publisher
Bahasa
eng
Lisensi
creativecommons.org/licenses/by-nc/4.0

Abstrak

Background: Patients with diabetes mellitus (DM) and cardiovascular disorders who suffer from COVID-19 may have an increased risk of death. Objective: This study aims to analyze the time of death and influencing factors in patients with DM and cardiovascular disorders with COVID-19. Methods: We used a retrospective observational cohort study using medical records of COVID-19 patients treated at Dr Soeradji and Penembahan Senopati hospitals from March 2020 to June 2022. There were 2,959 participants: patients without comorbidities, with DM, and with cardiovascular problems. We extracted sociodemographic and clinical data on patient characteristics using medical records. Data analysis used Kaplan-Meier and Cox regression analysis to estimate survival probability and investigate predictors of death with a 5% significance level. Results: The median survival time was highest in the group without comorbidities (70.00) and lowest in the DM+others group (21.75). Years of treatment, age, presence of comorbidities, and type of hospital were related to the survival rate of COVID-19 patients (p<0.05). Diabetes mellitus and cardiovascular system disorders are significantly associated with survival of COVID-19 patients (p<0.001). There were significant differences between patients without cardiovascular disorders and patients with cardiovascular disorders (Non-Hypertension, Hypertension, and Hypertension + Others) adjusted by year, gender, age, and hospital type (p<0.001). There were significant differences between patients without DM and patients with DM (DM only, DM+Hypertension, and DM+Others) adjusted by year, gender, age, and hospital type(p<0.001). Conclusion: Years of treatment, age, gender, comorbid DM, and cardiovascular problems are associated with the survival rate of COVID-19 patients. Older age, DM patients who have comorbidities other than hypertension, and patients with cardiovascular issues other than hypertension show a greater risk of death than other groups. Key words: COVID-19, Diabetes Mellitus, Hypertension, Cardiovascular Diseases, Survival Rate.

Kata kunci

Jaringan kolaborasi para penulis

40 penulis · 106 tautan kepenulisan bersama · 9 lintas organisasi · menampilkan 40 yang paling banyak terhubung

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Universitas Respati Yogyakarta
  • Taipei Medical University
  • National Taipei University of Nursing and Health Science
  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Sri SahayatiAfiliasi tidak diketahui3
Merita Eka RahmuniatiAfiliasi tidak diketahui2
Nazwar Hamdani RahilAfiliasi tidak diketahui2
Deden Iwan SetiawanAfiliasi tidak diketahui2
Wahyu Rochdiyat MurdhionoAfiliasi tidak diketahui2
Dewi SetyaningsihAfiliasi tidak diketahui2
Siti FadlilahTaipei Medical University1
Nazwar Hamdani RahilUniversitas Respati Yogyakarta1
Uswatun KhasanahUniversitas Respati Yogyakarta1
Ariyanto NugrohoUniversitas Respati Yogyakarta1
Fika Lilik IndrawatiNational Taipei University of Nursing and Health Science1
Yoni AstutiAfiliasi tidak diketahui1
Anisa Zuliana UtamiAfiliasi tidak diketahui1
Yoshihiko YanoAfiliasi tidak diketahui1
Wahyu Aristyaning PutriAfiliasi tidak diketahui1
. HartonoAfiliasi tidak diketahui1
Sukismanto SukismantoAfiliasi tidak diketahui1
SumardiyonoAfiliasi tidak diketahui1
Tri Rejeki AndayaniAfiliasi tidak diketahui1
Lala Budi FitrianaAfiliasi tidak diketahui1
Maria Denliana Polnesta ItaAfiliasi tidak diketahui1
Ariyanto NughrohoAfiliasi tidak diketahui1
Muflih MuflihAfiliasi tidak diketahui1
Hesti YuningrumAfiliasi tidak diketahui1
H Akhmad MaulaniAfiliasi tidak diketahui1
Suksmanto SukismantoAfiliasi tidak diketahui1
Merita Eka RahmuniyatiAfiliasi tidak diketahui1
Yelli Yani RusyaniAfiliasi tidak diketahui1
Ani FaridaAfiliasi tidak diketahui1
Ara’ Afliyatun Nur SariAfiliasi tidak diketahui1
Sunarto SunartoAfiliasi tidak diketahui1
Haryadi HaryadiAfiliasi tidak diketahui1
Ericka DarmawanAfiliasi tidak diketahui1
Tri Suwarni WahyudiningsihAfiliasi tidak diketahui1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OAI-PMH (metadata jurnal) http://stikbar.org/ycabpublisher/index.php/PHI/oai, pertama di-harvest 10 Nov 2026, terakhir terlihat 10 Nov 2026.
Metadata asli (oai_dc) 
<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Survival analysis of diabetes mellitus and cardiovascular patients with COVID-19: a secondary data analysis</dc:title>
	<dc:creator>Nugroho, Ariyanto</dc:creator>
	<dc:creator>Fadlilah, Siti</dc:creator>
	<dc:creator>Susanto, Herry</dc:creator>
	<dc:creator>Damayanti, Santi</dc:creator>
	<dc:creator>Suharto, Agus</dc:creator>
	<dc:creator>Sugiyarto, Sugiyarto</dc:creator>
	<dc:subject xml:lang="en-US">COVID-19, Diabetes Mellitus, Hypertension, Cardiovascular Diseases, Survival Rate</dc:subject>
	<dc:description xml:lang="en-US">
Background: Patients with diabetes mellitus (DM) and cardiovascular disorders who suffer from COVID-19 may have an increased risk of death. 
Objective: This study aims to analyze the time of death and influencing factors in patients with DM and cardiovascular disorders with COVID-19.


Methods: We used a retrospective observational cohort study using medical records of COVID-19 patients treated at Dr Soeradji and Penembahan Senopati hospitals from March 2020 to June 2022. There were 2,959 participants: patients without comorbidities, with DM, and with cardiovascular problems. We extracted sociodemographic and clinical data on patient characteristics using medical records. Data analysis used Kaplan-Meier and Cox regression analysis to estimate survival probability and investigate predictors of death with a 5% significance level. 


Results: The median survival time was highest in the group without comorbidities (70.00) and lowest in the DM+others group (21.75). Years of treatment, age, presence of comorbidities, and type of hospital were related to the survival rate of COVID-19 patients (p&amp;lt;0.05). Diabetes mellitus and cardiovascular system disorders are significantly associated with survival of COVID-19 patients (p&amp;lt;0.001). There were significant differences between patients without cardiovascular disorders and patients with cardiovascular disorders (Non-Hypertension, Hypertension, and Hypertension + Others) adjusted by year, gender, age, and hospital type (p&amp;lt;0.001). There were significant differences between patients without DM and patients with DM (DM only, DM+Hypertension, and DM+Others) adjusted by year, gender, age, and hospital type(p&amp;lt;0.001).


Conclusion: Years of treatment, age, gender, comorbid DM, and cardiovascular problems are associated with the survival rate of COVID-19 patients. Older age, DM patients who have comorbidities other than hypertension, and patients with cardiovascular issues other than hypertension show a greater risk of death than other groups.


Key words: COVID-19, Diabetes Mellitus, Hypertension, Cardiovascular Diseases, Survival Rate.
</dc:description>
	<dc:publisher xml:lang="en-US">YCAB Publisher</dc:publisher>
	<dc:date>2024-06-25</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://stikbar.org/ycabpublisher/index.php/PHI/article/view/788</dc:identifier>
	<dc:identifier>10.36685/phi.v10i2.788</dc:identifier>
	<dc:source xml:lang="en-US">Public Health of Indonesia; Vol. 10 No. 2 (2024): April - June; 143-156</dc:source>
	<dc:source>2477-1570</dc:source>
	<dc:source>2528-1542</dc:source>
	<dc:source>10.36685/phi.v10i2</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://stikbar.org/ycabpublisher/index.php/PHI/article/view/788/316</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2024 Ariyanto Nugroho, Siti Fadlilah, Herry Susanto, Santi Damayanti, Agus Suharto, Sugiyarto Sugiyarto</dc:rights>
	<dc:rights xml:lang="en-US">https://creativecommons.org/licenses/by-nc/4.0</dc:rights>
</oai_dc:dc>